Psyched Wellness (TSE:PSYC)
:PSYC
Want to see TSE:PSYC full AI Analyst Report?
Top Page
Psyched Wellness
(PSYC)
Select Model
Select Model
Rating:43Neutral
Price Target:
C$0.01
▼(-50.00% Downside)
Action:Reiterated
Date:06/13/26
The score is primarily held back by weak financial performance—large losses versus a small revenue base, worsening free cash flow, and a sharp equity decline indicating continued funding needs. Technicals also lean bearish with the price below key moving averages, while valuation is constrained by negative earnings and no dividend yield support.
Positive Factors
Positive gross profit
The company reports positive gross profit on initial product sales, indicating product-level economics that can support margins as volumes scale. If fixed costs are absorbed over time, these unit economics provide a pathway to durable margin improvement as commercialization advances.
Negative Factors
Accelerating negative free cash flow
Free cash flow is materially negative and worsening year-over-year, implying operations are not self-funding. Persistent negative FCF forces recurring capital raises or cost cuts, increasing dilution risk and constraining strategic investments over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive gross profit
The company reports positive gross profit on initial product sales, indicating product-level economics that can support margins as volumes scale. If fixed costs are absorbed over time, these unit economics provide a pathway to durable margin improvement as commercialization advances.
Read all positive factors
Psyched Wellness (PSYC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$4.07M
Dividend YieldN/A
Average Volume (3M)81.03K
Price to Earnings (P/E)―
Beta (1Y)-0.36
Revenue Growth-2.34%
EPS Growth-19.25%
CountryCA
Employees1,800
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-0.02
Shares Outstanding406,715,850
10 Day Avg. Volume36,477
30 Day Avg. Volume81,030
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.86
Price to Sales (P/S)12.22
P/FCF Ratio-1.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Psyched Wellness Business Overview & Revenue Model
Company Description
Psyched Wellness Ltd. operates as a health supplements enterprise, specializing in the production and distribution of artisanal medicinal mushrooms and their associated consumer packaged goods. A prominent offering is their Amanita Muscaria Tinctu...
How the Company Makes Money
Psyched Wellness generates revenue primarily through the sale of its Amanita muscaria–derived consumer wellness products under its own branding, including sales through direct-to-consumer channels (e.g., the company’s website) and through retail/w...
Psyched Wellness Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
42
Neutral
Cash Flow
24
Negative
| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 472.30K | 623.16K | 321.10K | 14.27K | 0.00 |
| Gross Profit | 189.79K | 241.89K | 155.71K | 7.54K | 0.00 |
| EBITDA | -5.08M | -4.52M | -3.32M | -4.29M | -65.14K |
| Net Income | -5.04M | -4.26M | -3.43M | -4.30M | -4.50M |
Balance Sheet | |||||
| Total Assets | 3.75M | 7.89M | 7.34M | 3.31M | 6.38M |
| Cash, Cash Equivalents and Short-Term Investments | 2.25M | 6.36M | 6.13M | 2.57M | 5.53M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 644.82K | 449.33K | 303.56K | 198.07K | 178.15K |
| Stockholders Equity | 3.10M | 7.44M | 7.03M | 3.11M | 6.20M |
Cash Flow | |||||
| Free Cash Flow | -4.05M | -3.11M | -3.11M | -3.18M | -3.04M |
| Operating Cash Flow | -4.05M | -3.10M | -3.03M | -3.09M | -3.01M |
| Investing Cash Flow | 0.00 | -2.78K | -44.84K | 126.99K | -28.58K |
| Financing Cash Flow | 0.00 | 3.39M | 6.64M | 0.00 | 6.51M |
Psyched Wellness Technical Analysis
Negative
0.02
Price Trends
0.01
Negative
0.01
Negative
0.02
Negative
Market Momentum
>-0.01
Negative
46.01
Neutral
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PSYC, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.01, and above the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.01 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:PSYC.
Psyched Wellness Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | C$1.50B | 20.31 | 15.25% | 2.67% | 12.52% | 37.38% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
45 Neutral | C$1.02M | -0.30 | -190.55% | ― | 3288.96% | 50.66% | |
44 Neutral | C$244.61M | -20.06 | -92.94% | ― | 119.70% | -368.06% | |
43 Neutral | C$4.07M | -0.52 | -70.53% | ― | -2.34% | -19.25% |
* Consumer Defensive Sector Average
TSE:PSYC
Psyched Wellness
0.01
-0.02
-60.00%
TSE:BITE
Blender Bites
0.15
0.00
0.00%
TSE:JWEL
Jamieson Wellness Inc
36.16
0.99
2.81%
TSE:HBFG
Happy Belly Food Group
1.65
0.52
46.02%
TSE:MOOO.X
Happy Supplements Inc.
0.35
-0.45
-56.25%
TSE:CULT
Cult Food Science Corp.
0.42
-0.59
-58.50%
Psyched Wellness Corporate Events
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and Financing
Psyched Wellness Raises Capital, Settles Debt in Shares and Tightens Ties With Lead Investor
Positive
Mar 20, 2026
Psyched Wellness has closed the first tranche of a non-brokered private placement, raising roughly C$860,000 through the issuance of common shares and warrants led by Gotham Green funds, and completed a shares-for-debt deal with Zerkalo that settl...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.